Building a community for bringing advanced and regenerative therapies to the patients

"Get Ready for Japan" training programme

Physical activity is not only important for fitness but also for overall health. This is confirmed by a new study conducted under the leadership of Prof. Dr. Maximilian Kleinert at the German Institute of Human Nutrition Potsdam-Rehbruecke (DIfE).…

Prospects for personalized medicine in Crohn’s disease

The Charité BIH Innovation team established a new event series to expand the matching and connecting activities and to create a broader platform: The Future Tech Days – where digital health startups and members of Charité meet for a short pitch…

Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) today signed a licence agreement with Qi Kang Medical, Ltd (QKM), a joint venture between Eckert & Ziegler and the Chinese company DC Pharma, for the cyclotron technology used by Eckert & Ziegler to…

- Berlin-based food tech company Formo develops fermentation processes to produce cheese alternatives.

- The €35 million EIB investment is backed by the European Union's InvestEU guarantee.

- This venture debt loan brings Formo’s total financing to…

Model was generated in only two months and sets new industry standard for performance

Daiichi Sankyo Company, Ltd (TSE: 4568) announced today that it will pay Glycotope $132.5 million to acquire intellectual property rights of the antitumor-associated mucin-1 (TA-MUC1) antibody, gatipotuzumab.

Researchers at the Experimental and Clinical Research Center in Berlin are developing a targeted treatment for muscular dystrophy with the help of gene-editing. Preclinical research led by the Spuler Lab published in “Nature Communications” now paves…